Application no. and date | 04011466.2 (espacenet) (Federated) (European Patent Register), 20010226 | Patent/reg. no. and date | DK/EP 1481992, 20161102 | Publication date | 20041201 | Priority no. and date | US 184601 P, 20000224, US 254465 P, 20001208, US 254498 P, 20001208 | EP pub. no. and date |
EP 1481992 20041201 | Effective date | | Applicant/owner | Eli Lilly & Company, Lilly Corporate Center
Indianapolis, IN 46285, US, WASHINGTON UNIVERSITY ST. LOUIS, 1 Brookings Drive,
St. Louis Missouri 63110, US | Applicant ref. no. | P20040136DK00E | Inventor | Holtzman, David, M., 368 Sunway
St. Louis
MO 63141, US, Demattos, Ronald, Ap.12S
4949 West Pine Boulevard
St. Louis
MO 63110, US, Bales, Kelly, R., 6376 S. 1000 E.
Cloverdale
IN 46120, US, Paul, Steven, M., 1145 Laurelwood
Carmel
IN 46032, US, Tsurushita, Naoya, 3719 Redwood Circle
Palo Alto
CA 94306, US, Vasquez, Maximiliano, 3813 Louis Road
Palo Alto
CA 94303, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61P 25/28 (2006.01) , C07K 16/18 (2006.01) , C12N 15/13 (2006.01) , C12N 5/10 (2006.01) | Title | Humaniserede antistoffer, som sekvestrerer amyloid-beta-peptid | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|